Taiwan FDA registration 6bd16b29f3262f1d51977297691ce8ac
Enbil anti-extractable nuclear antigen antibody immunoassay reagent
TW: 恩必爾抗可抽萃取核抗原抗體免疫試驗試劑
Taiwan·Risk Class 2·MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. INA LABORATORY·Registered Apr 16, 2007 – Apr 16, 2017ExpiredRegistration details
- Analysis ID
- 6bd16b29f3262f1d51977297691ce8ac
- Customs Code
- DHA00601825602
Company information
- Manufacturer Country
- Japan
- Authorized Representative
- Jingxiang Co., Ltd
Product details
- Intended Use
- It is used to screen for antibodies such as anti-ENA (RNP, Sm, SS-A, SS-B and Scl-70) in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5100 抗核抗體免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Apr 16, 2007
- Expiry Date
- Apr 16, 2017
About this record
Access comprehensive regulatory information for Enbil anti-extractable nuclear antigen antibody immunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6bd16b29f3262f1d51977297691ce8ac and manufactured by MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. INA LABORATORY. The authorized representative in Taiwan is Jingxiang Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices